✦ LIBER ✦

Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

✍ Scribed by Steven Boonen; Dennis M. Black; Cathleen S. Colón-Emeric; Richard Eastell; Jay S. Magaziner; Erik Fink Eriksen; Peter Mesenbrink; Patrick Haentjens; Kenneth W. Lyles

Book ID: 109131966
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 226 KB
Volume: 58
Category: Article
ISSN: 0002-8614
DOI: 10.1111/j.1532-5415.2009.02673.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Yearly Zoledronic Acid 5 mg o

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

✍ Pierre D Delmas; Francoise Munoz; Dennis M Black; Felicia Cosman; Steven Boonen; 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 653 KB

Relationship of changes in total hip bon

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

✍ Richard M Jacques; Steven Boonen; Felicia Cosman; Ian R Reid; Douglas C Bauer; D 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi